ABSTRACT: This study investigates the impact of wage structure on employee satisfaction, motivation, and retention in Thailand’s textile manufacturing industry. Despite the recognized importance of ...

Shares of Agios Pharmaceuticals AGIO tanked about 51% on Wednesday after it reported mixed top-line results from the phase III RISE UP study, which evaluated orally administered Pyrukynd (mitapivat) ...

Nov 19 (Reuters) - Agios Pharmaceuticals (AGIO.O), opens new tab said on Wednesday its sickle cell disease drug met one of its two main goals in a late-stage study of patients aged 16 and older but ...

In its mission to grow the reach of its pyruvate kinase (PK) activator Pyrukynd (mitapivat), Agios Pharmaceuticals has come up short of producing an unequivocal win in the key indication of sickle ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...

Pyrukynd, which Agios sells for a rare type of anemia, missed one of its main objectives in a study seen as crucial for its commercial outlook and the company’s reinvention. Uptake for the genetic ...

The Trump administration on Thursday designated four European Antifa groups as global terrorist networks. “Antifa Ost in Germany, International Revolutionary Front in Italy, and the Greek groups Armed ...

This year, Big Pharma has been active on the M&A front in cell and gene therapy (CGT), with AbbVie setting down $2.1 billion for Capstan Therapeutics’ novel CAR T therapies, Eli Lilly dropping $1.3 ...

In a new study published in Nature Communications titled, “The reference genome of the human diploid cell line RPE-1,” researchers from University of Rome La Sapienza have produced the first reference ...

1 Department of Gynecology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China 2 Department of Pathology, Longhua Hospital, Shanghai University of Traditional ...